Ultromics

Oxford, United Kingdom

Ultromics develops AI-driven cardiology solutions to assist in cardiovascular disease diagnosis through echocardiography.

$55.0M raised

Jul 2025

Series C

Top Investors

UCM VenturesLightrockOptum VenturesFuture Planet CapitalNina Capital

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Ultromics raised?

Ultromics has raised $55.0M in total funding. The most recent round was Series C. The last funding was announced in July 2025.

Who are Ultromics's investors?

Ultromics's investors include UCM Ventures, Lightrock, Optum Ventures, Future Planet Capital, Nina Capital.

Where is Ultromics headquartered?

Ultromics is headquartered in Oxford, United Kingdom.

What does Ultromics do?

Ultromics develops AI-driven cardiology solutions to assist in cardiovascular disease diagnosis through echocardiography.

What stage is Ultromics at?

Ultromics is at the Series C stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 31, 2025.

MLA

"Ultromics — Funding & Investors." VCBacked, July 31, 2025, https://www.vcbacked.co/company/ultromics. Accessed June 3, 2026.

APA

VCBacked. (2025). Ultromics — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/ultromics

Wikipedia (cite web)

{{cite web |title=Ultromics — Funding & Investors |url=https://www.vcbacked.co/company/ultromics |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 31, 2025.